Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2026-02-26 @ 4:17 PM
Study NCT ID:
NCT03125902
Status:
COMPLETED
Last Update Posted:
2024-03-26
First Post:
2017-04-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC)
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-08-25
Start Date Type:
ACTUAL
Primary Completion Date:
2019-11-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-17
Completion Date Type:
ACTUAL
First Submit Date:
2017-04-20
First Submit QC Date:
None
Study First Post Date:
2017-04-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-11-10
Results First Submit QC Date:
None
Results First Post Date:
2021-01-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-01
Last Update Post Date:
2024-03-26
Last Update Post Date Type:
ACTUAL